Does tolerance develop to the anxiolytic effects of septal lesions?

Physiology and Behavior

Volumn 59, Issue 2, 1996, Pages 311-318

  Menard, Janet ^a   Treit, Dallas ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Anxiety; Anxiolytic effects; Plus maze; Septal lesions; Shock probe burying; Tolerance

Indexed keywords

ANXIOLYTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; ATTENUATION; BEHAVIOR; BRAIN INJURY; CONTROLLED STUDY; HISTOLOGY; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIZATION; SEPTUM PELLUCIDUM; TRANQUILIZING ACTIVITY;

EID: 0029912228     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/0031-9384(95)02095-0     Document Type: Article

References (31)

1. De Boer, S. F.; Slangen, J. L.; Van der Gugten, J. Plasma catecholamine and corticosterone levels during active and passive shock-probe avoidance behavior in rats: Effects of chlordiazepoxide. Pharmacol. Biochem. Behav. 47:1089-1098; 1990.
2. Domjan, M.; Burkhard, B. The principles of learning and behavior. Pacific Grove, CA: Brooks/Cole; 1993:44-46.
3. File, S. E. One-trial tolerance to the anxiolytic effects of chlordiazepoxide in the plus-maze. Psychopharmacology 100:281-282; 1990.
4. File, S. E.; Andrews, N.; Wu, P. Y.; Zharkovsky, A.; Zangrossi, H., Jr. Modification of chlordiazepoxide's behavioral and neurochemical effects by handling and plus-maze experience. Eur. J. Pharmacol. 218:9-14; 1992.
5. File, S. E.; Mabbutt, P. S.; Hitchcott, P. K. Characterisation of the phenomenon of "one-trial tolerance" to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze. Psychopharmacology 102:98-101; 1990.
6. File, S. E.; Zangrossi, H., Jr. "One-trial tolerance" to the anxiolytic actions of benzodiazepines in the elevated plus-maze, 01 the development of a phobic state? Psychopharmacology 110:240-244; 1993.
7. Gray, J. A. The neuropsychology of anxiety: An enquiry into the functions of the septo-hippocampal system. New York: Oxford University Press; 1982.
8. Gray, J. A.; McNaughton, N. Comparison between the behavioral effects of septal and hippocampal lesions: A review. Neurosci. Biobehav. Rev. 7:119-188; 1983.
9. Lee, C.; Rodgers, R. J. Antinociceptive effects of elevated plus-maze exposure: Influence of opiate receptor manipulations. Psychopharmacology 102:507-513; 1990.
10. Lister, R. G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92:180-185; 1987.
11. McKim, W. A. Drugs and behaviour: An introduction to behavioral pharmacology (2nd ed.). Englewood Cliffs, NJ: Prentice Hall; 1991.
12. Miczek, K. A.; Kelsey, J. E.; Grossman, S. P. Time course of effects of septal lesions on avoidance response suppression, and reactivity to shock. J. Comp. Physiol. Psychol. 2:318-327; 1972.
13. Paxinos, G.; Watson, C. The rat brain in stereotaxic coordinates. 2nd ed. New York: Academic Press; 1986.
14. Pellow, S. Anxiolytic and anxiogenic drug effects in a novel test of anxiety: Are exploratory models of anxiety in rodents valid? Meth. Find. Exp. Clin. Pharmacol. 8:557-565; 1986.
15. Pellow, S.; Chopin, P.; File, S. E.; Briley, M. Validation of open:closed arm entries in the elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Meth. 14:149-167; 1985.
16. Pellow, S.; File, S. E. Anxiolytic and anxiogenic drug effects on exploratory activity in the elevated plus-maze: A novel test of anxiety in the rat. Pharmacol. Biochem. Behav. 24:525-529; 1986.
17. Pesold, C.; Treit, D. Excitotoxic lesions of the septum produce anxiolytic effects in the elevated plus-maze and the shock-probe burying tests. Physiol. Behav. 52:37-47; 1992.
18. Pesold, C.; Treit, D. The septum and the amygdala differentially mediate the anxiolytic effects of benzodiazepines. Brain Res. 638:295-301; 1994.
19. Pinel, J. P. J.; Puttaswamaiah, S.; Wilkie, D. M. Extinction of conditioned defensive burying. Behav. Processes 10:101-110; 1985.
20. Rodgers, R. J.; Lee, C.; Shepherd, J. K. Effects of diazepam on behavioral and antinociceptive responses to the elevated plus-maze in male mice depend upon treatment regimen and prior maze experience. Psychopharmacology 106:102-110; 1992.
21. Treit, D. Evidence that tolerance develops to the anxiolytic effect of diazepam in rats. Pharmacol. Biochem. Behav. 22:383-387; 1985.
22. Treit, D. A comparison of anxiolytic and nonanxiolytic agents in the shock-probe/burying test for anxiolytics. Pharmacol. Biochem. Behav. 36:203-205; 1990.
23. Treit, D. A comparison of the effects of septal lesions and anxiolytic drugs on defensive behaviour in rats. Psychol. Rec. 41:217-231; 1991.
24. Treit, D. Anxiolytic effects of benzodiazepines and 5-HT1A agonists: Animal Models. In: Rodgers, R. J.; Cooper, S. J., eds. 5-HT1a Agonists, 5-HT3 antagonists and benzodiazepines: Their comparative behavioral pharmacology. New York: John Wiley; 1991:107-131.
25. Treit, D.; Pesold, C. Septal lesions inhibit fear reactions in two animal models of anxiolytic drug action. Physiol. Behav. 47:365-371; 1990.
26. Treit, D.; Pinel, J. P. J.; Fibiger, H. C. Conditioned defensive burying: A new paradigm for the study of anxiolytic agents. Pharmacol. Biochem. Behav. 15:619-626; 1981.
27. Treit, D.; Menard, J.; Pesold, C. The shock-probe burying test. Neurosci. Protocols Module 3:9-17; 1994.
28. Treit, D.; Menard, J.; Royan, C. Anxiogenic stimuli in the elevated plus-maze. Pharmacol. Biochem. Behav. 44:463-469; 1993.
29. Treit, D.; Pesold, C.; Rotzinger, S. Dissociating the anti-fear effects of septal and amygdaloid lesions using two pharmacologically validated models of rat anxiety. Behav. Neurosci. 107:770-785; 1993.
30. Treit, D.; Robinson, A.; Rotzinger, S.; Pesold, C.. Anxiolytic effects of serotonergic interventions in the shock-probe burying test and the elevated plus-maze test. Behav. Brain Res. 54:23-34; 1993.
31. Tsuda, A.; Yoshishige, I.; Tanaka, M. The contrasting effects of diazepam and yohimbine on conditioned defensive burying in rats. Psychobiol. 16:213-217; 1988.